Skip to content

Oncomed Pharmaceuticals Inc OMED Stock Analysis

  • Nasdaq
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$0.89 unchanged at close Apr 23

Last close · Previous close $0.89

Market cap
At the Apr 23 close
P/E ratio
On last 12 months’ EPS
Diluted EPS
Last 12 months
Dividend yield
Last 12 months

Price chart

$0.89unchangedTue, Apr 23 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$0.89Apr 22
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Valuation

Financials

Dividends

About Oncomed Pharmaceuticals Inc

DELISTED - OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential targets and pathways critical to CSC self-renewal and differentiation; and develop targeted antibody and other protein-based therapeutics that are designed to modulate these CSC targets and inhibit the growth of CSCs. The Company anti-cancer therapeutics include anti-DLL4 (demcizumab, OMP-21M18), Anti-DLL4/Anti-VEGF Bispecific, and Anti-Notch2/3 (OMP-59R5), Anti-Notch1 (OMP-52M51, Anti-Fzd7, Fzd8-Fc, RSPO-LGR.

Sector
Industry
Headquarters
Exchange
Nasdaq
Asset type
Common stock
Price history since

OMED news

OMED stock FAQ

What is OMED stock’s price today?

Oncomed Pharmaceuticals (OMED) traded at $0.89 at the close on , unchanged from the previous close of $0.89.

What exchange does OMED trade on?

Oncomed Pharmaceuticals trades on the Nasdaq under the ticker symbol OMED. Its price history on this dashboard begins on .

Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

Contact Ryan

Get in touch

Contact Me

Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.